Therefore, it is highly recommended the clinical involvement of corticosteroid and selective COX-2 inhibitors in treating CRSwNP patients in Taiwan and other countries with similar COX-2 endotyping. This evidence concerns the gene PTGS2 and chronic rhinosinusitis with nasal polyps.